Achieving life sciences sector growth requires falling medicine payment rates To tackle the economic stagnation of the last 15 years, the UK needs a strategy that aligns policy across government departments and avoids perverse incentives.

Achieving life sciences sector growth requires falling VPAG payment rates.

In this piece, @TorbettR explains the drivers behind the UK's historic underinvestment in medicine and the unprecedented opportunity to address the issue in 2025.
www.abpi.org.uk/media/blogs/...

To see the blog I posted this week on why we’ll be proposing a ‘course correct’ on VPAG. It’s an important scheme and we need it to work. Current rates will damage competitiveness unless we find a solution